Matthew Cato
Senior Director Cell & Gene Therapy • Mission Bio
Matthew Cato is a business and market development leader who specializes in cell and gene therapies and precision medicine. With a background in immunology and biotechnology, he focuses on strategic commercial development for single-cell technology to advance cell and gene therapeutic solutions
Also Speaking
Matthew Hewitt
Executive Director, Scientific Services, Cell and Gene Therapy • Charles River
11 November 2022
Jaeseung Lim
Chief Executive Officer & Chief Scientific Officer • Cellatz Therapeutics
27 October 2022
Also Speaking
2025 Downloadable Agenda
Download the post-event report for Advanced Therapies Week 2024.
8 October 2024
